Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.
about
Long term Suboxone™ emotional reactivity as measured by automatic detection in speech.Methadone disposition in oral fluid during pharmacotherapy for opioid-dependenceCrushed and injected buprenorphine tablets: characteristics of princeps and generic solutions.Buprenorphine vs methadone treatment: A review of evidence in both developed and developing worlds.The nature of methadone diversion in England: a Merseyside case studyValidity of Self-Reported Drug Use Information Among Pregnant Women.Self-reported psychopathology and health-related quality of life in heroin users treated with methadoneProvision of opioid substitution therapy services in Australian pharmacies.Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a randomized trial.Probuphine® (buprenorphine implant): a promising candidate in opioid dependence.Buprenorphine and buprenorphine/naloxone soluble-film for treatment of opioid dependence.Buprenorphine-naloxone buccal soluble film for the treatment of opioid dependence: current update.Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder: A Randomized Clinical Trial.Buprenorphine implants in medical treatment of opioid addiction.Behavioral characteristics and injection practices associated with skin and soft tissue infections among people who inject drugs: A community-based observational study.Quantitative testing of buprenorphine and norbuprenorphine to identify urine sample spiking during office-based opioid treatment.What is diversion of supervised buprenorphine and how common is it?Challenges and opportunities in using wastewater analysis to measure drug use in a small prison facility.Injecting buprenorphine-naloxone film: Findings from an explorative qualitative study.Diversion of methadone and buprenorphine from opioid substitution treatment: patients who regularly sell or share their medication.Diversion and injection of methadone and buprenorphine among clients in public opioid treatment clinics in New South Wales, Australia.Use of street methadone in italian heroin addicts presenting for opioid agonist treatment.Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients.Advances in the delivery of buprenorphine for opioid dependence.Increasing diversion of methadone in Vancouver, Canada, 2005-2015.Exploring prison buprenorphine misuse in the United Kingdom: a qualitative study of former prisoners.Challenges in implementing opioid agonist therapy in Lebanon: a qualitative study from a user's perspective.A comparison of privileged access interviewing and traditional interviewing methods when studying drug users in treatment
P2860
Q30452109-7297FAEB-5258-4D10-8D4D-A505366D3332Q34448467-15338F2B-7618-4726-9904-4F7419E0DAD2Q34634396-11E6EFC5-2DCE-4EB9-BFBA-55775FF0AC86Q35733030-86FB09D6-0907-47F8-A088-1DCB3F4ACFD6Q35774742-FB26208D-7E8E-44D6-B21D-A23C2D304867Q36463778-F9A69875-91D3-47E3-8C2A-C1745C60D413Q36500166-EA8347DC-8CA9-4BCD-AA68-B20FFB2CC983Q36583499-0712C27D-450C-49AC-8745-674DEF7377C8Q37282456-44817332-0A27-4063-9C36-A9CDC9D0B009Q37705253-BA776AAC-5779-4C31-B8B1-FACF221679A7Q38046650-78934FE4-C0E5-4B53-835D-70D359B50298Q38243268-6A8E3BEB-BE24-4AA7-A841-BA0A3D26BBA7Q38374886-E5FFA059-3EA3-463E-A7D0-A957497BC3ADQ38750450-89A2D79D-BF35-4D86-BCDD-11D97C3BB677Q39145843-BE1E1A79-F459-4735-ABDA-E724DA637299Q39444972-72BB94BB-E6B5-4FB7-B440-B88AB309D31DQ39900680-0FACFEB1-1146-4DC7-837B-1AD7B337D1ABQ40225755-CA7BFCB2-E00F-433F-8A56-CF95E5F2335FQ40731745-2BBA6AFC-E14A-4991-B422-F902D866C5D6Q41703547-D74D5626-3282-4636-807F-BE55A4510B5FQ43213071-9070C73D-2695-48A8-916E-8583F7FFC089Q44345468-82620AB1-10E1-4359-8515-7938FFBB5057Q44349623-7A3C8E8F-813F-47A0-8C09-DFE0A61C2C21Q45946172-163E7F8E-086F-4216-8350-4834ACE0E506Q47226505-F7FF94F7-B2F5-4BEF-99F2-18584FD9DF07Q48305929-082EA24C-879E-453B-BCA1-22E4D0B20BBAQ52577389-B13837CD-8079-4B93-8A74-AD0C4301E182Q58251062-B0093D39-90B5-4BEA-8CA0-596C68A2CB68
P2860
Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Prevalence of diversion and in ...... in New South Wales, Australia.
@en
Prevalence of diversion and in ...... in New South Wales, Australia.
@nl
type
label
Prevalence of diversion and in ...... in New South Wales, Australia.
@en
Prevalence of diversion and in ...... in New South Wales, Australia.
@nl
prefLabel
Prevalence of diversion and in ...... in New South Wales, Australia.
@en
Prevalence of diversion and in ...... in New South Wales, Australia.
@nl
P1476
Prevalence of diversion and in ...... in New South Wales, Australia.
@en
P2093
Adam R Winstock
P304
P356
10.1016/J.DRUGPO.2007.03.002
P577
2008-03-21T00:00:00Z